Epidemic Trajectory in the Absence of Non-Pharmacological Interventions in India: An Insight into Post Vaccine Introduction Phase
Background: Non-Pharmacological Interventions (NPIs) have proven to be effective in controlling and reducing the spread of SARS-CoV-2 in the population. During the year 2020, before vaccine introduction, India has been through various phases of COVID-19 pandemic response such as nationwide lockdown phase 1 to 4 and unlock phases 1-8. Although India’s vaccination program against COVID-19 has started, it is still in the initial phases and considering the humongous population of India, coverage of entire population with vaccine needs time.
Methodology: We designed a model showing the projections of expected incident cases of COVID-19 under two scenarios for the month of February 2021. In the first scenario, Rt value expected to be observed during February 2021 if all the NPIs are removed was considered. In the second scenario, Rt value projected as per the current trend with NPIs in place was considered. Model projections of both these scenarios were done for India and also for Delhi.
Result: Our simulation model quantifies the effect of Non-pharmacological interventions on the current pandemic situation in India and Delhi, which concludes that relaxation in preventive measures or COVID-19 appropriate behaviors or ceasing of NPIs shall see an exponential rise in the daily incident cases. Comparing the trajectories for India and Delhi, it can be deduced that if NPIs cease to exist for one month, the daily incident cases can be many times higher of normal in India and also in Delhi by the end of February 2021.
Conclusion: NPIs remain to play a major role in containing the spread and minimizing the effects of COVID-19 pandemic. Any kind of relaxation in NPIs can lead to sudden surge of incident cases and correspondingly may increase the death toll.
How to cite this article:
Athotra A, Ramaswamy S, Dhuria M, Patil AD, Kishore J, Jain SK et al. Epidemic Trajectory in the Absence of Non-Pharmacological Interventions in India: An Insight into Post Vaccine Introduction Phase. Epidem Int 2020; 5(4): 16-21.
Andrews MA, Areekal B, Rajesh KR et al. First confirmed case of COVID-19 infection in India: A case report. The
Indian Journal of Medical Research 2020; 151(5): 490.
Ministry of Health and Family Welfare. COVID-19 Vaccine Rollout. 16 JAN 2021 9:05PM by PIB Delhi.
Accessed Feb 10, 2021. Available from:https://pib.gov.in/PressReleasePage.aspx?PRID=1689180
Ministry of Health and Family Welfare. COVID-19 Vaccine Rollout. 17 JAN 2021 9:05PM by PIB Delhi.
Accessed Feb 10, 2021. Available from:https://pib.gov.in/PressReleasePage.aspx?PRID=1689167
MoHFW. Frequently Asked Questions. Accessed Feb 10, 2021. Available from:https://www.mohfw.gov.in/
Patel P, Athotra A, Vaisakh TP et al. NCDC COVID Incident Management Team. Impact of nonpharmacological
interventions on COVID-19 transmission dynamics in India. Indian J Public Health 2020; 64: S142-6.
h t t p s : / / w w w. b b c . c o m / n e w s / w o r l d - a s i a -india-55945382
Buss LF, Prete CA, Abrahim CM et al. COVID-19 Herd Immunity in the Brazilian Amazon. Infectious
Diseases (except HIV/AIDS); 2020. doi:10.1101/2020.09.16.20194787
Signorelli C, Zucchi A, Tersalvi CA et al. High seroprevalence of SARS_COV-2 in Bergamo: evidence
for herd immunity or reason to be cautious? Int JPublic Health 2020; 65(9): 1815-1817. DOI:10.1007/
The Scientist. News article. A study estimates that 76% of the population of the city of Manaus in Brazil has
been exposed to Covid. Dec 14, 2020. Available from: https://www.the-scientist.com/news-opinion/studyestimates-76-percent-of-brazilian-city-exposed-tosars-cov-2-68272
Kumar N, Bhartiya S, Singh T. Duration of anti-SARSCoV-2 antibodies much shorter in India. Vaccine 2020
Nov. DOI: 10.1016/j.vaccine.2020.10.094.
Copyright (c) 2021 Epidemiology International (E-ISSN: 2455-7048)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.